52 Bone metabolism and quality of life of postmenopausal women with invasive breast cancer receiving neoadjuvant hormonal therapy: sub-analyses from celecoxib anti-aromatase neoadjuvant (CAAN) trial
L.W.C. Chow, A.Y.S. Yip, W.T.Y. Loo, C.C.P. Yiu, M. ToiVolume:
8
Year:
2010
Language:
english
DOI:
10.1016/s1359-6349(10)70083-5
File:
PDF, 62 KB
english, 2010